New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 28, 2014
14:09 EDTESALYEisai carcinoma treatment granted FDA orphan designation
According to a post on the FDA's website, Eisai's lenvatinib for the treatment of hepatocellular carcinoma has been granted orphan designation. Reference Link
News For ESALY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 23, 2015
10:00 EDTESALYOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
05:53 EDTESALYEisai upgraded to Overweight from Equal Weight at Barclays
Barclays upgraded Eisai (ESALY) to Overweight citing Biogen's (BIIB) positive BIIB037 data for Alzheimer's disease. The firm believes BIIB037 could potentially change the standard of treatment.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use